You are here: Industry Insights > Recarbrio

News List

Novel antibiotic Recarbrio has launched in the UK pharmatimes
November 20, 2020
MSD’s novel antibiotic treatment Recarbrio has launched in the UK as concerns grow over the rise of antimicrobial resistance (AMR) globally.
FDA Approves Recarbrio americanpharmaceuticalreview
June 15, 2020
The U.S. Food and Drug Administration (FDA) approved Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) ...
FDA approves Recarbrio for treatment of bacterial pneumonias europeanpharmaceuticalreview
June 09, 2020
Recarbrio (imipenem-cilastatin and relebactam) was approved for the treatment of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP).
Merck’s sNDA for RECARBRIO Wins FDA Approval contractpharma
June 08, 2020
For the treatment of hospital-acquired and ventilator-associated bacterial pneumonia caused by Gram-negative microorganisms.
FDA approves Merck’s antibiotic drug to treat hospital-acquired bacterial pneumonia expresspharma
June 05, 2020
The US Food and Drug Administration approved Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years of age and older.
EMA recommends five drugs for approval after December meeting europeanpharmaceuticalreview
December 17, 2019
The EMA’s CHMP has adopted a positive opinion for five medicines and recommended extending the indications for eight more.
US Food and Drug Administration approves Recarbrio europeanpharmaceuticalreview
August 05, 2019
A three-drug combination injection to treat patients with complicated urinary tract and intra-abdominal infections has been approved by the FDA.
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections drugs
July 22, 2019
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections.
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections drugs
July 19, 2019
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections.
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections drugs
July 18, 2019
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections.

Previous page 1 2 Next page